Antiproliferation and apoptosis induced by tamoxifen in human bile duct carcinoma QBC939 cells via upregulated p53 expression |
| |
Authors: | Peng Han Jin-He Kang Hua-Liang Li Hui-Hui Lian Jian Zhang Qing-Xi Chen |
| |
Affiliation: | a Key Laboratory of Ministry of Education for Cell Biology and Tumor Cell Engineering, School of Life Sciences, Xiamen University, Xiamen 361005, China b First Hospital Attached to Fujian Medical University, Xiamen 361004, China c Key Laboratory for Chemical Biology of Fujian Province, Xiamen University, Xiamen 361005, China |
| |
Abstract: | Tamoxifen (TAM) is a nonsteroidal antiestrogen that has been used in the treatment of breast cancer for over 30 years. Recently, it was shown that TAM also has efficacy on gastrointestinal neoplasms such as hepatocarcinoma and pancreatic carcinoma, and that the chemopreventive activities of TAM might be due to its abilities to inhibit cell growth and induce apoptosis. In the present study, we investigated the effects of tamoxifen on growth and apoptosis in the human bile duct carcinoma (BDC) cell line QBC939 using MTT assay, inverted microscopy, fluorescence microscopy, transmission electron microscopy, classic DNA fragmentation agarose gel electrophoresis assay, PI single- and FITC/PI double-staining flow cytometry, and Western blotting. Our data revealed that TAM could significantly inhibit growth and induce apoptosis in QBC939 cells. Increased expression of p53 was observed in TAM-treated cells, indicating that p53 might play an important role in TAM-induced apoptosis in QBC939 cells. These results provide significant insight into the anticarcinogenic action of TAM on BDC. |
| |
Keywords: | Tamoxifen Bile duct carcinoma Antiproliferation Apoptosis p53 |
本文献已被 ScienceDirect 等数据库收录! |
|